Teva Presents New Data for SD-809 in Huntington Disease at 68th American Academy of Neurology (AAN) Annual Meeting in Vancouver, B.C.
Go back to Teva Presents New Data for SD-809 in Huntington Disease at 68th American Academy of Neurology (AAN) Annual Meeting in Vancouver, B.C.| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 38.25 +1.16 (3.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.09 | 52 Week High | $66.55 | |||
| Open | $37.66 | 52 Week Low | $37.82 | |||
| Day High | $38.34 | P/E | N/A | |||
| Day Low | $37.00 | EPS | $0.00 | |||
| Volume | 818,742 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 38.25 +1.16 (3.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.09 | 52 Week High | $66.55 | |||
| Open | $37.66 | 52 Week Low | $37.82 | |||
| Day High | $38.34 | P/E | N/A | |||
| Day Low | $37.00 | EPS | $0.00 | |||
| Volume | 818,742 | |||||
